High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours
dc.contributor.author | Cheong, K. | |
dc.contributor.author | Perry, D. | |
dc.contributor.author | Karapetis, C. | |
dc.contributor.author | Koczwara, B. | |
dc.date.issued | 2004 | |
dc.description | The definitive version may be found at www.wiley.com | |
dc.description.abstract | <h4>Background</h4>Peripherally inserted central catheters (PICC) have been used extensively as a cost-effective and safe form of medium-term intravascular access. There are only limited data about complications of PICC lines in oncology patients despite theoretical concerns about the higher risks of complications in these patients as a result of cancer itself and cancer therapy.<h4>Aims</h4>To document the frequency and type of PICC complications in patients with solid tumours.<h4>Methods</h4>All patients with solid tumours who were treated at Flinders Medical Centre, Adelaide, South Australia, Australia between January 2000 and March 2001 were included in a retrospective review of PICC complications.<h4>Results</h4>Twenty-seven PICC lines were inserted in 17 patients; 40.7% (11/27) of PICC lines developed complications requiring early removal of the PICC. Complications encountered were sepsis (systemic and cellulitis), thrombosis, blockage and leakage. Septic complications were found at a rate of 8/1000 PICC days or 25.7% (7/27) of PICC inserted. The median dwell time was 20 days. The mean time for a complication to occur was 27.5 days.<h4>Conclusions</h4>The present study demonstrates a high rate of complications, which is higher than the complication rates reported in studies of non-oncology patients. PICC lines should be used with caution in patients with solid tumours. Prospective studies of the factors influencing the incidence of complications might be warranted. | |
dc.description.statementofresponsibility | K. Cheong, D. Perry, C. Karapetis and B. Koczwara | |
dc.description.uri | http://www.ncbi.nlm.nih.gov/pubmed/15151668 | |
dc.identifier.citation | Internal Medicine Journal, 2004; 34(5):234-238 | |
dc.identifier.doi | 10.1111/j.1444-0903.2004.00447.x | |
dc.identifier.issn | 1444-0903 | |
dc.identifier.issn | 1445-5994 | |
dc.identifier.uri | http://hdl.handle.net/2440/54914 | |
dc.language.iso | en | |
dc.publisher | Blackwell Publishing Asia | |
dc.source.uri | https://doi.org/10.1111/j.1444-0903.2004.00447.x | |
dc.subject | Humans | |
dc.subject | Neoplasms | |
dc.subject | Thrombophlebitis | |
dc.subject | Critical Illness | |
dc.subject | Antineoplastic Agents | |
dc.subject | Catheterization, Central Venous | |
dc.subject | Catheterization, Peripheral | |
dc.subject | Retrospective Studies | |
dc.subject | Catheters, Indwelling | |
dc.subject | Female | |
dc.subject | Male | |
dc.subject | Infections | |
dc.title | High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours | |
dc.type | Journal article | |
pubs.publication-status | Published |